Early Decisions That Matter: Managing Smoldering and Newly Diagnosed Myeloma | Rafat Abonour, MD

What are the most important early treatment decisions for patients with smoldering multiple myeloma and newly diagnosed multiple myeloma? In this informative discussion, Rafat Abonour explains how early choices in monitoring, risk assessment, and treatment planning can have a major impact on long-term outcomes and quality of life.

In this educational session, Dr. Abonour explains the differences between Smoldering Multiple Myeloma and Multiple Myeloma and presents studies related to early treatment of Smoldering Myeloma.